Invention Grant
- Patent Title: Compositions and methods of using modified release solabegron for lower urinary tract symptoms
-
Application No.: US15951968Application Date: 2018-04-12
-
Publication No.: US10751311B2Publication Date: 2020-08-25
- Inventor: Eliot Ohlstein , Raymond E. Stevens, Jr. , H. Jeffrey Wilkins
- Applicant: VELICEPT THERAPEUTICS, INC.
- Applicant Address: US PA Wayne
- Assignee: Velicept Therapeutics, Inc.
- Current Assignee: Velicept Therapeutics, Inc.
- Current Assignee Address: US PA Wayne
- Agency: Troutman Pepper Hamilton Sanders LLP
- Main IPC: A61K31/196
- IPC: A61K31/196 ; A61K9/20 ; A61K9/50 ; A61K9/16 ; A61K9/24 ; A61K45/06 ; A61K9/00 ; A61P31/10
Abstract:
This application relates to pharmaceutical compositions, comprising solabegron that are useful for the treatment of lower urinary tract symptoms such as, for example, overactive bladder and prostate disorders. Additionally, this application relates to methods for treating lower urinary tract symptoms utilizing the pharmaceutical compositions, comprising solabegron. In some embodiments, the pharmaceutical compositions, comprising solabegron comprise a dual release drug delivery system.
Public/Granted literature
- US20190083434A1 COMPOSITIONS AND METHODS OF USING MODIFIED RELEASE SOLABEGRON FOR LOWER URINARY TRACT SYMPTOMS Public/Granted day:2019-03-21
Information query
IPC分类:
